Skip to main content
Premium Trial:

Request an Annual Quote

Tempus: Scott Gottlieb

Tempus has named former US Food and Drug Administration Commissioner Scott Gottlieb to its board of directors. Gottlieb headed the FDA from May 2017 until April 2019. In the 2000s, he was the agency's deputy commissioner for medical and scientific affairs and later a senior advisor to the former FDA Commissioner. An internal medicine physician, Gottlieb also had a stint as senior advisor to the administrator for the centers for Medicare and Medicaid Services, where he helped implement the Medicare Part D drug benefit. He also spent 10 years as a venture capitalist with New Enterprise Associates. He remains a resident fellow of the American Enterprise Institute, a conservative think tank.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.